Repeated PPV effective for macular holes

Article

Repeated pars plana vitrectomy, with internal limiting membrane peeling and gas tamponade, is a safe and effective treatment technique for persistent macular holes, states an investigation in the Journal of Retinal and Vitreous Diseases.

Repeated pars plana vitrectomy (PPV), with internal limiting membrane peeling and gas tamponade, is a safe and effective treatment technique for persistent macular holes, states an investigation in the journal Retina.

A retrospective study, led by Dr E. Moissesiev, Department of Ophthalmology, Tel Aviv Sourasky Medical Center, Tel Aviv, Israel, involved 29 eyes that underwent repeated pars plana vitrectomy and limiting membrane peeling. The group obtained demographic information, visual acuity before the first and second operations, MH diameter before and after both surgical procedures and throughout the follow-up. Additional details retrieved included surgical details, time between surgeries, final visual acuity and the occurrence of any complications.

Reoperation caused the closure of persistent MH in 68.9% of the eyes and final visual acuity significantly improved, compared to results from before the second surgery.

In total, 62% of patients gained >2 lines after reoperation, with shorter interoperative time and smaller initial MH diameter significantly correlating with better visual prognosis.

The abstract can be viewed here.

Newsletter

Join ophthalmologists across Europe—sign up for exclusive updates and innovations in surgical techniques and clinical care.

Recent Videos
A photo of Seville, Spain, with the Congress on Controversies in Ophthalmology logo superimposed on it. Image credit: ©francovolpato – stock.adobe.com; logo courtesy COPHy
Anat Loewenstein, MD, Professor and Director, Department of Ophthalmology, Tel Aviv Medical Center, discusses the Congress on Controversies in Ophthalmology (COPHy)
Anat Loewenstein, MD, speaks about the 22nd Annual Angiogenesis, Exudation, and Degeneration Meeting in February 2025 and shares her global forecast for AI-driven home OCT
Sarah M. Thomasy, DVM, PhD, DACVO, a veterinary ophthalmologist at UC Davis, talks about how her research at the Glaucoma 360 symposium
I. Paul Singh, MD, an anterior segment and glaucoma specialist, discusses the Glaucoma 360 conference, where he participated in a panel discussion on the use of artificial intelligence (AI) in glaucoma care.
Charles Wykoff, MD, PhD, discusses his Floretina ICOOR presentation topic, retinal non-perfusion in diabetic retinopathy, with David Hutton, editor of Ophthalmology Times
Elizabeth Cohen, MD, discusses the Zoster Eye Disease study at the 2024 AAO meeting
Victoria L Tseng, MD, PhD, professor of ophthalmology and glaucoma specialist, UCLA
© 2025 MJH Life Sciences

All rights reserved.